Precision-cut Human Tissue Slices
Precision-cut human tissue slices are thin, uniform slices of tissue cut from excised human organs which are maintained in a cultured environment. This approach allows the tissues to retain their intact architecture without any alterations.
Precision-cut Human Tissue Slice Applications
- Drug discovery and development: Ideal for studying drug mechanisms of action, pharmacokinetics (ADME), and drug metabolism, as well as assessing drug efficacy and safety, including toxicity screening.
- Disease modelling and biomarker discovery: Enables investigation of disease mechanisms, identification of potential therapeutic targets, and discovery of biomarkers for disease progression and treatment response.
- Cancer and immunotherapy research: Facilitates the study of tumour microenvironments, immune cell-tissue interactions, and the development of immunotherapies such as CAR-T cells, antibodies, and vaccines.
- Gene therapy and personalised medicine: Supports testing of genetic engineering tools like CRISPR/Cas9 and patient-specific therapies using tissues from individual donors.
- Infectious disease and environmental research: Offers a platform to study host-pathogen interactions, test antiviral or antibacterial agents, and investigate the effects of environmental toxins on human tissues.
Precision-cut Human Tissue Slice Advantages
- Superior physiological relevance: Retain the full cellular complexity, gene expression patterns, and 3D structural integrity of native human tissues, thus maintaining critical cell-to-cell and cell-to-matrix interactions. This enables studies that closely mimic in vivo conditions, surpassing the limitations of 2D cell culture models.
- Representative data: The preserved architecture and cellular diversity of these tissue slices yield data that is more predictive of human responses in both physiological and pathological states, improving the translational relevance of preclinical research.
- Advanced experimental flexibility: The ability to integrate perfusion systems introduces controlled delivery of nutrients, oxygen, and therapeutic agents while removing waste products. This dynamic culture environment extends tissue viability, functionality, and experimental timeframes, supporting long-term studies and high-complexity experiments.
- Bridge between pre-clinical models and the clinic: Offer a unique platform that combines the controlled environment of in vitro systems with the complexity of human biology, reducing the reliance on animals and accelerating the path to clinical applications.
Precision-cut Human Tissue Slice Limitations
- Tissue availability: Access to high-quality tissue samples is often restricted due to reliance on a limited number of donors. This can constrain the scale of experiments and the ability to achieve statistically significant results.
- Sample variability: Biological variability between donors can affect the consistency and reproducibility of results. This poses challenges in standardising protocols and generating reliable data across different studies.
- Limited lifespan: Sustaining the viability and functionality of fresh human tissue over prolonged periods necessitates advanced culture systems and precise environmental controls. These requirements can be costly and reduce the scalability of experiments.